About us
Our Company
Our Leadership
Precision Research
GPCRs in IO
Our innovative approach
Our Programs
Partnerships
Our Collaborations
Our Partners
News & Media
Press releases
News
Downloads
Opportunities
Partnering Opportunities
Career opportunities
Search on our website
Type Enter to start searching.
Pipeline
Scroll to explore
Latest
Scroll back top
6 June 2024
Domain Therapeutics strengthens its intellectual property for its series of Treg depleting anti-CCR...
Discover more
17 April 2024
Domain Therapeutics appoints Sean A. MacDonald as Chief Executive Officer
Discover more
2 April 2024
Domain Therapeutics to participate at premier investor and healthcare conferences
Discover more
26 March 2024
Domain Therapeutics to present latest data on DT-9045, a first-in-class Negative Allosteric Modulat...
Discover more
12 March 2024
Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 ...
Discover more
8 March 2024
indice d’égalité femmes-hommes 2024
Discover more
27 February 2024
Domain Therapeutics promotes Stephan Schann as Chief Scientific Officer (CSO)
Discover more
8 February 2024
Domain Therapeutics further strengthens leadership team with appointment of Sean A. MacDonald as Ch...
Discover more
25 January 2024
Domain Therapeutics awarded Hospital-University Research in Health (RHU) SPRINT consortium grant to ...
Discover more
8 January 2024
Domain Therapeutics strengthens leadership team to spearhead global development and North American e...
Discover more